SG/PUT/NOVO-NORDISK B/600/0.1/20.06.25 Share Price

Warrant

DE000SU9CVW0

Market Closed - Boerse Frankfurt Warrants 01:08:07 06/07/2024 am IST
0.22 EUR -4.35% Intraday chart for SG/PUT/NOVO-NORDISK B/600/0.1/20.06.25
Current month+4.76%
1 month-8.33%
Date Price Change
05/24/05 0.22 -4.35%
04/24/04 0.23 0.00%
03/24/03 0.23 +9.52%
02/24/02 0.21 +10.53%
01/24/01 0.19 -9.52%

Real-time Boerse Frankfurt Warrants

Last update July 06, 2024 at 01:08 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU9CVW
ISINDE000SU9CVW0
Date issued 14/02/2024
Strike 600 kr
Maturity 20/06/2025 (350 Days)
Parity 10 : 1
Emission price 0.58
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.65
Lowest since issue 0.18
Delta0x
Omega 0.000000
Premium0x
Gearing55.51x
Moneyness 0.6160
Difference Strike -374 kr
Difference Strike %-62.33%
Spread 0.01
Spread %4.17%
Intrinsic value 0.000000
Present value 0.2350

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974 DKK
Average target price
952.2 DKK
Spread / Average Target
-2.24%
Consensus